Exploring the Potential of Intranasal Ketamine for Chronic Migraine Relief

June 28, 2023 by Steve Suntala

Migraines affect millions of people worldwide, causing debilitating pain and disrupting daily life. Despite various treatment methods available, many individuals continue to experience limited relief. However, there is a promising alternative on the horizon: intranasal ketamine infusion therapy. In recent research from Medscape, Hsiangkuo Yuan, MD, Ph.D., briefly discusses the new treatment option for migraines and sheds some light on its efficacy, mechanisms of action, and benefits.

In our study, we showed that with even a few uses per day, intranasal ketamine can still improve patients’ quality of life,” Dr. Hsiangkuo Yuan states. He then went on to mention that these were patients who had been failed by multiple medications already, and were currently seeking any form of relief.

Understanding Ketamine Infusion Therapy

Ketamine, initially developed as an anesthetic in the 1960s, has since gained recognition for its unique properties. It works by interacting with certain receptors in the brain, leading to pain relief and altering perception.

Different forms of ketamine administration exist, including infusion therapy, intravenous (IV) therapy, and intranasal spray. Each form has its benefits and considerations, and the choice depends on the individual’s needs and the healthcare professional’s recommendation.

Ketamine Infusion Therapy for Migraines

Ketamine infusion therapy has emerged as a preferred method for administering ketamine to migraine patients. During this process, ketamine is administered intravenously in a controlled medical setting. The dosage and duration of treatment sessions vary based on individual needs, and medical professionals closely monitor the patients throughout the process.

Many migraine patients have reported significant success and relief through ketamine infusion therapy. The treatment has demonstrated efficacy in reducing the frequency, intensity, and duration of migraines, thus improving overall quality of life. It is important to consult with healthcare professionals experienced in ketamine therapy to determine if this approach is suitable for your specific condition.

Research on the use of ketamine for migraine treatment is still ongoing, but the preliminary results are promising. Studies like the one mentioned above have shown that ketamine may effectively alleviate migraine pain and provide relief when conventional medications fall short. Its ability to modulate certain neurotransmitters and interrupt pain pathways in the brain makes it an intriguing option for those seeking a breakthrough in migraine management.

Compared to traditional migraine medications, ketamine offers a different approach and a potential solution for patients who have not found relief with existing treatments. However, it is important to note that ketamine should be considered as a complementary therapy and not a standalone solution.

Potential Side Effects and Precautions

Like any medical treatment, ketamine infusion therapy carries potential side effects. However, under proper administration and monitoring, these side effects are generally well-tolerated and short-lived. Patients may experience temporary dissociation, changes in perception, or mild nausea during or after the treatment. It is crucial to work with experienced healthcare professionals who can guide and support you throughout the process.

Ketamine infusion therapy may not be suitable for everyone, and certain patient groups should exercise caution. Individuals with a history of substance abuse, uncontrolled high blood pressure, or certain cardiac conditions may have contraindications for ketamine treatment. A thorough medical evaluation is necessary to determine the suitability and safety of ketamine therapy for each individual.

*Please note that at New Pathways, our team cannot treat patients for migraines unless there is a referral from the doctor who is already treating them for migraines.

Ketamine Infusions for Migraines at New Pathways

The potential of ketamine infusion therapy for migraine treatment gives hope to individuals who have struggled with conventional options. Although more research is needed, the preliminary evidence suggests that ketamine can provide significant relief and improve the overall well-being of migraine patients.

As we move forward, it is essential to continue exploring the possibilities of ketamine treatment for migraines and invest in further research and clinical applications. At New Pathways Clinic, we strive to pave the way for a future where migraines no longer hold individuals back from living their lives to the fullest by offering ketamine (IV) infusion therapy.

If you are interested in learning more about ketamine infusion therapy for migraines or want to explore if it is the right option for you, reach out to our knowledgeable team at New Pathways Clinic. Together, we can embark on a journey toward a new path of migraine relief and improved quality of life.

At New Pathways Clinic our heartfelt mission is to establish a holistic mental wellness campus that touches the lives of individuals in the greater Cleveland, Columbus, and Cincinnati regions. We are dedicated to combining state-of-the-art mental health treatments, like Ketamine therapy infusions and Spravato nasal spray, with the expertise of compassionate mental health professionals to treat depression, anxiety, PTSD, migraines, and bipolar disorder.

Our unwavering commitment drives us to continuously evolve and adapt as the scientific landscape of ketamine research expands and diversifies, leading to innovative mental health treatments. We are determined to pave the way for a healthier future for Cleveland, central Ohio, and southern Ohio.

New Pathways Clinic also offers Semaglutide & Tirzepatide weight-loss shots, ketamine-assisted psychotherapy, and  ketamine/Spravato support groups for patients.

Keep In Touch

Stay informed on ketamine treatments, Spravato, and mental-health wellness at New Pathways Clinic in Cleveland via our free newsletter.

© New Pathways 2024